Survey Conducted At An Academic Medical Center Revealed Knowledge Gaps of Transthyretin Amyloidosis Cardiomyopathy Predominantly In Primary Care Providers

Transthyretin amyloidosis (ATTR) is a progressive, fatal disease caused by the formation of amyloid fibrils that misfold and accumulate in various tissue in the body, including the heart, leading to a form of heart failure called transthyretin amyloidosis cardiomyopathy (ATTR-CM). ATTR-CM consists of two subgroups: a wild-type (ATTR-wt) or an inherited mutant autosomal dominant gene (hATTR). ATTR-wt and hATTR have an estimated median survival 3.6 years and 2.5 years after diagnosis, respectively.
Source: Journal of Cardiac Failure - Category: Cardiology Authors: Tags: 145 Source Type: research

Related Links:

More News: Academia | Amyloidosis | Cardiology | Cardiomyopathy | Genetics | Heart | Heart Failure | Primary Care